Trial intelligence / Profile preview

IHP with Melphalan for Metastatic Colorectal Cancer

NCT00089401Phase 2Completed

Sponsor
National Institutes of Health
Start
Jul 2004
Primary completion
Nov 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of melphalan in colorectal cancer (CRC), sponsored by National Institutes of Health. Started Jul 2004; status: completed.

02

Drugs

melphalan
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00089401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00089401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call